China SXT Pharmaceuticals, Inc.
SXTC · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $1,006 | $11,519 | $15,143 | $46,582 |
| - Cash | $18,099 | $12,070 | $17,368 | $15,524 |
| + Debt | $984 | $2,647 | $3,757 | $2,046 |
| Enterprise Value | -$16,109 | $2,096 | $1,531 | $33,104 |
| Revenue | $1,741 | $1,928 | $1,972 | $2,602 |
| % Growth | -9.7% | -2.2% | -24.2% | – |
| Gross Profit | $367 | $554 | $426 | $1,252 |
| % Margin | 21.1% | 28.7% | 21.6% | 48.1% |
| EBITDA | -$2,573 | -$2,351 | -$5,208 | -$5,051 |
| % Margin | -147.8% | -121.9% | -264.1% | -194.1% |
| Net Income | -$3,304 | -$3,099 | -$5,935 | -$5,736 |
| % Margin | -189.8% | -160.7% | -301% | -220.4% |
| EPS Diluted | -8.18 | -3.57 | -22.23 | -137.92 |
| % Growth | -129.1% | 83.9% | 83.9% | – |
| Operating Cash Flow | -$2,345 | -$1,928 | -$81 | $268 |
| Capital Expenditures | -$2 | -$7 | -$71 | -$62 |
| Free Cash Flow | -$2,347 | -$1,935 | -$151 | $206 |